Sterling
Moderna logo
Moderna
AstraZeneca logo
AstraZeneca

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Moderna 0.145, AstraZeneca 15.384.

Moderna vs AstraZeneca Net Worth and Market Cap

Moderna (MRNA) and AstraZeneca (AZN) are peers in Vaccines. Moderna reported revenue of $145M as of Q2 2026, compared with $15.4B for AstraZeneca. AstraZeneca leads on revenue.

Moderna's gross margin is 35.9% versus 83.6% for AstraZeneca. Moderna's net margin is -539.3% versus 16.3% for AstraZeneca.

Key differences

  • Revenue growth from Q2 2025 to Q2 2026: AstraZeneca +6.4%, Moderna +2.1%.
  • AstraZeneca made an operating profit in its latest quarter (20.6% margin); Moderna made an operating loss (-562.1%).
  • Moderna's KPIs on Sterling include Cash, Cash Equivalents and Investments (Quarterly) and Net Product Sales vs Deferred Revenue (Quarterly).
  • AstraZeneca's KPIs on Sterling include Alliance Revenue by Partnered Medicine (Quarterly) and AZD5004 + AZD6234 Trial Timeline: Oral GLP-1 + Oral Amylin.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Moderna, AstraZeneca.
MetricModernaAstraZeneca
Market Cap--
Revenue$145.00M$15.38B
Cost of Revenue$93.00M$2.52B
Gross Profit$52.00M$12.86B
Operating Income$-815.00M$3.16B
Net Income$-782.00M$2.51B
R&D Expense$651.00M$4.05B
Earnings Per Share-$1.96$1.59
Gross Margin35.9%83.6%
Operating Margin-562.1%20.6%
Net Profit Margin-539.3%16.3%
Free Cash Flow$-563.00M$2.13B
Cumulative Free Cash Flow$7.37B$121.22B
Operating Cash Flow$-526.00M$2.89B
Cash & Equivalents$1.72B$4.89B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites